. 2010 Dec 29;20(9):1491–1501. doi: 10.1089/scd.2010.0373

Table 2.

Cardiac Function, Clinical Parameters, and Mobilization of BM-CPCs Immediately Pre- and Post- and at 3, 6, and 12 Months Postcoronary Angiography in the Control Group Without Bone Marrow Cell Transplantation

	Immediately precoronary angiography	Immediately postcoronary angiography	3 months after coronary angiography	6 months after coronary angiography	12 months after coronary angiography
Global EF (%)	46 ± 10		47 ± 7^a		46 ± 9^a
The size of infarct area (%)	29 ± 9		28 ± 9^a		26 ± 8^a
Infarct wall movement velocity (cm/s)	1.86 ± 0.96		1.93 ± 0.76^a		1.99 ± 0.9^a
LVEDV (mL)	141 ± 28		142 ± 31^a		140 ± 30^a
LVESV (mL)	76 ± 17		75 ± 15^a		76 ± 16^a
SVI (mL/m)	36 ± 10		35 ± 8^a		34 ± 9^a
CD34/45+ BM-CPCs	200 ± 50	198 ± 53^a	212 ± 89^a	200 ± 75^a	205 ± 80^a
CD133/45+ BM-CPCs	51 ± 38	51 ± 25^a	57 ± 28^a	64 ± 25^a	58 ± 19^a
BNP (pg/mL)	169 ± 95		128 ± 97^a	138 ± 59^a	125 ± 70^a
NYHA classification	2.50 ± 0.9		2.30 ± 0.7^a	2.40 ± 0.7^a	2.29 ± 0.9^a

Values are mean ± SD.

There was no significant difference in baseline cardiac function, clinical function status parameters, as well as mobilization of BM-CPCs between both groups at baseline.

^{^a}

P = not significant.

BM-CPCs, bone marrow-derived circulating progenitor cells; NYHA, New York Heart Association; BNP, B-type natriuretic peptide; EF, ejection fraction; LVEDV, end-diastolic volume; LVESV, end-systolic volume; SVI, stroke volume index.